The Galien Foundation Announces 2025 Prix Galien USA Nominees for "Best Digital Health Solution," "Best Medical Technology," "Incubators, Accelerators and Equity," and "Best Startup"

News provided by

Aug 27, 2025, 15:28 ET

NEW YORK, Aug. 13, 2025 /PRNewswire/ -- The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, today announced the 2025 Prix Galien USA Award nominees for "Best Digital Health Solution," "Best Medical Technology," "Incubators, Accelerators and Equity," and "Best Startup." Winners will be announced during the Prix Galien USA Awards Ceremony on October 30, 2025, at the American Museum of Natural History in New York City.

"As Jury Chair, I am honored to recognize these exceptional nominees who exemplify the transformative power of innovation in medical technology, digital health, and entrepreneurship," said Kenneth C. Frazier, Chair of the Jury, Prix Galien USA Awards Committee. "Their groundbreaking work represents the future of healthcare and our shared commitment to improving lives through scientific excellence."

The 2025 Prix Galien USA nominees include products from the following categories: "Best Digital Health Solution" – 25 nominees; "Best Medical Technology" – 25 nominees; "Best Incubators, Accelerators and Equity" - 12 nominees, and "Best Startup" - 53 nominees. To explore this year's nominees in all award categories, please click here.

To qualify, each candidate must be U.S. Food and Drug Administration (FDA) approved for marketing within the last five years and demonstrate tremendous potential to improve human health. Sales data are not considered by the nominating committee in their award nominee selection, only science and health impact.

Best Digital Health Solution (Nominees)

Abbott	NeuroSphere™ Virtual Clinic
AdhereTech	Aidia System
All4Cure, Inc.	All4Cure Platform, MyelomaMap (TM), TrialMatchMM
Aptar Digital Health	Migraine Buddy's Weather and Trigger Advanced Reports
Beaconcure	Verify
Cleerly	Cleerly LABS Plaque Analysis
Clinical ink	GlucoseReady (TM)
DNAnexus + Boehringer Ingelheim Joint Submission	Project PRISM/Project CRYPTx
Empatica	Empatica Health Monitoring Platform
Evinova	Unified Trial Solution
First Ascent Biomedical Inc	xDRIVE/DxPP - Ex Vivo Drug Response Identification & Validation Engine / Drug Prediction Platform
Future Doctor Limited	MedGPT - AI Digital Twin of Doctors
Helfie AI	Helfie AI
MPA	MyPsychAdmin – The only AI solution that frees Mental Health Practitioners from computers/admin so they can spend more time with their patients.
Mymee	Mymee's product is a proprietary personalized trial & care platform for rheumatic autoimmune patients who can no longer control disease flares with prescription therapies.
NeuraLight	NeuraLight platform
Otsuka Precision Health, Inc.	Rejoyn^®
ŌURA	Oura Ring 4
Patientory, Inc.	Patientory Digital Health Data Wallet
RapidAI	Rapid Aneurysm
Recursion	Recursion Operating System (OS): end-to-end AI-driven drug discovery and development platform
TECHMEDO Inc.	Healthcare Operating System
University of Rochester - Wilmot Cancer Institute	University of Rochester - Wilmot Cancer Institute's Hyperion
WARD 24/7	WARD Clinical Support System (WARD-CSS)
Wheel	Wheel Horizon

Best Medical Technology (Nominees)

Abbott	Esprit™ BTK Everolimus Eluting Resorbable Scaffold System
Abbott	AVEIR™ Dual Chamber (DR) Leadless Pacemaker System
Abbott	TriClip™ G4 System
Alcon	TOTAL30^® Soft Contact Lenses
Beyond Air, Inc.	LungFit^® PH
bioMérieux	BIOFIRE^® SPOTFIRE^® System and BIOFIRE^® SPOTFIRE^® Respiratory/Sore Throat (R/ST) Panel
BioProtect	BioProtect Balloon Spacer
Body Vision Medical LTD.	LungVision^®
Boston Scientific	FARAPULSE™ Pulsed Field Ablation System
Cresilon	TRAUMAGEL^®
Edwards Lifesciences	Edwards SAPIEN 3 Ultra RESILIA Transcatheter Aortic Heart Valve
Edwards Lifesciences	Edwards EVOQUE Transcatheter Tricuspid Valve Replacement System
ENDOLOGIX LLC	DETOUR System
Establishment Labs Holdings Inc.	Motiva Flora^® SmoothSilk^® Tissue Expander
Guardant Health	Guardant360^® CDx
Impulse Dynamics	Optimizer^® Smart Mini System
Medtronic	MiniMed™ 780G automated insulin delivery system
Medtronic	Symplicity Spyral™ Renal Denervation System
Medtronic	Inceptiv™ SCS
OUR United Corporation	TaiChiPro^®
Perspectum	CoverScan
Polarean	XENOVIEW HPX System
RefleXion Medical	RefleXion^® X1 with SCINTIX^® biology-guided radiotherapy
Smith & Nephew, Inc.	CORI Surgical System
Terumo Aortic	Thoraflex Hybrid

Best Incubators, Accelerators and Equity (Nominees)

AVANT BIO	AVANT BIO Fund II LP
Calibr-Skaggs Institute for Innovative Medicines	Calibr-Skaggs Drug Accelerator
Cornell University	Center for Life Science Ventures
Cross-Border Impact Ventures	Women's and Children's Health Technology Fund
Cube Labs	Cube Labs
EIT Health	EIT Health Accelerator
Endless Frontier Labs	Endless Frontier Labs
MATTER	SMILE Health
Mayo Clinic	Mayo Clinic and Arizona State University Alliance for Health Care Accelerator
McGill Dobson Centre for Entrepreneurship	McGill Dobson Centre for Entrepreneurship
Nucleate	The Activator
OROT - CIUSSS West-Central Montreal	OROT - Connected Health Incubator, CIUSSS West Central (Montréal)

Best Startup (Nominees)

Actipulse Neuroscience	Actipulse
Adaptilens, Inc.
ADVANCED BIODESIGN
ALGA BIOLOGICS	ALGA BIOLOGICS
Ascidian Therapeutics
BigHat Biosciences	Milliner™
Bitterroot Bio
Bloqcube Inc.
Canary Medical	Canary Medical
Click Therapeutics	Prescription Digital Therapeutics
CUTISS AG
Dren Bio
Duo Oncology	Duo Oncology
Esperto Medical, Inc.
Ganymed Robotics	Ganymed Robotics
Gatehouse Bio, Inc.
Geneos Therapeutics	GNOS-PV02+INO-9012 followed by intradermal electroporation. Personalized Therapeutic Cancer Vaccine
Gleamer
Hope Medicine
Imaginostics, Inc.
Immunis, Inc.
Insilico Medicine
Intrepid Labs
Kapsule	Kapsule Terminal
LEAF4Life, Inc.
Libera Bio S.L.	MPN Technology
magAssist Co., Ltd.
Mammoth Biosciences
Manus Neurodynamica	NeuroMotor Pen™
MediVIE Tech
Micron Biomedical, Inc.
Navigation Sciences, Inc.
Nona Biosciences
Nospharma
Paradigm Therapeutics
Qubit Pharmaceuticals	Qubit Pharmaceuticals
Quercis
REGEnLIFE
Resuscitec GmbH
SEED Therapeutics Inc.
Seismic Therapeutic
SFA Therapeutics, Inc.
Shenzhen ReeToo Biotechnology Co., Ltd.
SIMEDYS	SIMEDYS
SmartBiotic	Antimicrobial Management by Smartbiotic
Strand Therapeutics
SURGE Therapeutics
TargED Biopharmaceuticals B.V.
Turbine Simulated Cell Technologies Limited
ViCardia Therapeutics, Inc.
Vocxi Health	MyBreathPrint
XaTek Inc.	ClotChip
Zest Health	Zest Health

Bruno Cohen, Chairman of The Galien Foundation, commented, "We are honored to recognize this year's outstanding Prix Galien USA nominees, whose innovation in medical technology, digital health, and entrepreneurship demonstrates the progress that moves healthcare forward. Their achievements reveal the extraordinary potential of science to change lives."

Prix Galien Best Medical Technology, Best Digital Health Solution, Best Incubator / Accelerator / Equity, and Best Startup Committee 2025

Kenneth C. FRAZIER
Committee Chair, Former Chairman & CEO Merck

Roch DOLIVEUX
Honorary CEO, UCB

Dr. Mikael DOLSTEN
Former Chief Scientific Officer & President, Pfizer Research and Development

Alex GORSKY
Former CEO & Executive Chairman, Johnson & Johnson

Penny HEATON
Global Therapeutic Area Head, Vaccines, Janssen

Sheri McCOY
Board of Directors, AstraZeneca, Former CEO, Avon

Joel S. MARCUS
Executive Chairman & Founder, Alexandria

Elias ZERHOUNI
Former Head of Global R&D, Sanofi

About The Galien Foundation
The Galien Foundation fosters, recognizes, and rewards excellence in scientific innovation to improve the state of human health. Our vision is to be the catalyst for the development of the next generation of innovative treatments and technologies that will impact the state of medical practice and save lives. The late Professor Elie Wiesel, 1986 Peace Nobel Laureate, is The Honorary Founding President of The Galien Foundation

The Foundation oversees and directs activities in the US for the Prix Galien, an international awards program dedicated to progress through innovative medicines development, with chapters in 14 countries, Africa and an inaugural chapter established in India in 2024. The Prix Galien was created in 1970 by Roland Mehl in honor of Galen, the father of medical science and modern pharmacology. Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize in biopharmaceutical research.

For more information, visit www.galienfoundation.org.

Follow the Foundation on social media:
https://www.facebook.com/GalienFoundation/
https://twitter.com/GalienFdn
https://www.linkedin.com/company/the-galien-foundation/

Media Contact:
Kara Bradley
Finn Partners
[email protected]
646-213-7243

SOURCE The Galien Foundation